... behavioural psychological symptoms of dementia, disruptive behaviour disorders, autism) and RISPERDAL(R), CONSTA(TM) (schizophrenia). ...
... behavioural psychological symptoms of dementia, disruptive behaviour disorders, autism) and RISPERDAL(R), CONSTA(TM) (schizophrenia). ...
That version of the drug, Risperdal Consta, is manufactured by Alkermes and already has achieved blockbuster status by exceeding $1.1 billion in annual ...
Johnson & Johnson's (NYSE: JNJ) and Alkermes' (Nasdaq: ALKS) Risperdal Consta, which had sales of $1.1 billion last year, is the only long-acting atypical ...
The only approved drug similar to long-acting Zyprexa is Risperdal Consta, which is sold by a subsidiary of New Jersey-based Johnson & Johnson. ...
all 8 news articles
The only approved drug similar to long-acting Zyprexa is Risperdal Consta, which is sold by a subsidiary of New Jersey-based Johnson & Johnson. ...
Alkermes manufactures RISPERDAL ® CONSTA ® , marketed by Janssen-Cilag (Janssen, LP), a wholly owned division of Johnson & Johnson, and developed and ...
Zyprexa Adhera would compete with Johnson & Johnson's long-acting schizophrenia injection called Risperdal Consta. Lilly shares rose 43 cents to $52.09 in ...
Alkermes manufactures RISPERDAL® CONSTA®, marketed by divisions of Johnson & Johnson, and developed and manufactures VIVITROL®, marketed in the US primarily ...